Navigation Links
DrugRisks Update: Warning Added to Pradaxa For Blood Condition
Date:5/8/2013

Chicago, IL (PRWEB) May 08, 2013

The medication resource center DrugRisks.com is announcing new information on the site for patients taking the blood thinner Pradaxa. The maker of the drug recently updated label warnings to include the risk of a blood platelet disorder*.

DrugRisks was created to improve the safety of patients taking popular prescription drugs by providing the latest warnings, recalls, studies and legal news. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.

Health experts have disagreed over whether Pradaxa has higher risks of internal bleeding than traditional anticoagulants. The FDA has stated the drug is as safe as warfarin**. However, the Institute for Safe Medication Practices recently ranked drugs like Pradaxa among the most dangerous, and warned that Pradaxa bleeding may be 5 times as likely to result in death than bleeding from warfarin or Coumadin***.

The resource center has also added a study from the University of Illinois at Chicago suggesting the data used by the FDA may be flawed, and the risk for Pradaxa bleeding may be higher than expected****.

Now, DrugRisks has learned that the maker of the drug, Boehringer Ingelheim, recently added a new Pradaxa side effect warning to the label advising of the risk of thrombocytopenia, a drop in blood platelets that can result in Pradaxa internal bleeding*.

With a growing number of patients filing a Pradaxa lawsuit alleging internal bleeding, cases have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to speak with a lawyer about their legal options. Due to the specialized nature of federal drug injury cases, DrugRisks only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugRisks.com today for more information on the research, Pradaxa side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*Boehringer Ingelheim, 4/30/13; us.boehringer-ingelheim.com/news_events/press_releases/press_release_archive/2013/04-30-13-boehringer-ingelheim-pharmaceuticals-prescribing-information-pradaxa-dabigatran-etexilate-mesylate.html
**FDA 11/2/12; http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
***Institute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****New England Journal of Medicine, 4/4/13; nejm.org/doi/full/10.1056/NEJMp1302834

Read the full story at http://www.prweb.com/releases/pradaxa-internal-bleeding/side-effects/prweb10709493.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Update: Use of NuvaRing Drops Amid Injury Allegations
2. DrugRisks News Update: Bayer Loses Yaz Patent as Blood Clot Settlements Continue
3. DrugRisks Adds Update From Court Ordering Mediation of Stryker Hip Lawsuits
4. DrugRisks Update: Federal Court Schedules First Mirena Lawsuit Hearing
5. DrugRisks Legal Update: Jury to Decide Actos Cancer Trial This Week
6. DrugRisks Update: Doctor Testifies Actos Main Cause of Bladder Cancer in Trial
7. DrugRisks Adds Study Showing Pradaxa Viral Infection Risk
8. DrugRisks Stryker Recall Update: Company Warns Investors as Patients Alleging Injury Ask to Send Lawsuits to Federal Court
9. DrugRisks Center NuvaRing Lawsuit News: Drug Maker May Have Concealed Risks
10. DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
11. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual ... in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon ... fun run is geared towards children of all ages; it is a non-competitive, non-timed ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. ... big data solutions, today announced that its MyDario product is expected to ... TV listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, ... ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound energy ... ... Jim Bertolina, PhD ... Tom Tefft ... executive Josh Stopek , PhD, who has led R&D and business development teams at ...
Breaking Medicine Technology: